RU
EN

PFO Occluder

Occluder for Patent Foramen Ovale

Occlutech | PFO Occluder / Occluder for Patent Foramen Ovale

Occlutech | PFO Occluder / Occluder for Patent Foramen Ovale

Occlutech | PFO Occluder / Occluder for Patent Foramen Ovale

Occlutech | PFO Occluder / Occluder for Patent Foramen Ovale

Occlutech | PFO Occluder / Occluder for Patent Foramen Ovale

Description

The Flex II PFO Occluder allows physicians to simplify implantation and achieve cutting-edge results¹ through rapid training. Over 33,000 PFO occluders have been implanted in more than 70 countries worldwide with record effectiveness and safety².

Advantages

  • The unique spherical connection between the pushrod and the occluder ensures a secure fixation while freely adapting to the anatomy. Once positioned, the occluder is easily and quickly deployed.

  • The biocompatible handmade PET patch allows immediate verification of occlusion using ultrasound and X-ray imaging.

  • Nitinol coated with titanium oxide demonstrates superior biocompatibility³ and minimal nickel release⁴.

  • Optimized weaving: the absence of a hub and reduced material on the left atrial disc ensure better tissue integration.
Brochure Occlutech PFO Occluder

Excellent Product Features

Links to Content
  1. Percutaneous Closure of the Patent Foramen Ovale with Occlutech: Safety and Efficacy Registry (OPPOSE), multicenter registry, UK.
  2. 2018_Snijder Closure of PFO in 250 patients and 1300 patient-years of follow-up using the Occlutech Figulla device.
  3. Castleman L.S., et al. Biocompatibility of Nitinol Alloy as Implant Material. Journal of Biomedical Materials Research | 97 6; 10: 695.
  4. Electrochemical Characteristics of Nitinol Occluder, Institute of Natural and Medical Sciences, University of Tübingen, mNI <0.014 μg / (cm * day).